Average Co-Inventor Count = 6.11
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ambrx, Inc. (13 from 113 patents)
2. Celgene Corporation (2 from 549 patents)
15 patents:
1. 10047151 - Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
2. 9365640 - Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
3. 9260472 - Modified human four helical bundle polypeptides and their uses
4. 9175083 - Antigen-binding polypeptides and their uses
5. 8906676 - Modified human four helical bundle polypeptides and their uses
6. 8907064 - Modified human four helical bundle polypeptides and their uses
7. 8778880 - Human growth hormone modified at position 35
8. 8232371 - Modified human interferon polypeptides and their uses
9. 8143216 - Modified human growth hormone
10. 8119603 - Modified human interferon polypeptides and their uses
11. 8097702 - Modified human interferon polypeptides with at least one non-naturally encoded amino acid and their uses
12. 8093356 - Pegylated human interferon polypeptides
13. 7939496 - Modified human growth horomone polypeptides and their uses
14. 7638299 - Biosynthetic polypeptides utilizing non-naturally encoded amino acids
15. 7632924 - Antigen-binding polypeptides and their uses